Skip to Content

NitroMist Approval History

FDA Approved: Yes (First approved November 2, 2006)
Brand name: NitroMist
Generic name: nitroglycerin
Dosage form: Lingual Aerosol
Company: NovaDel Pharma
Treatment for: Angina

NitroMist is an oral spray formulation of nitroglycerin indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.

Development History and FDA Approval Process for NitroMist

DateArticle
Nov  2, 2006Approval NitroMist NovaDel Pharma - Treatment for Angina Pectoris
May 26, 2006FDA Accepts Submission for NitroMist as Complete Response
Jun  2, 2005NovaDel Pharma Receives Approvable Letter from the FDA for NitroMist - nitroglycerin lingual aerosol
Sep 29, 2004NovaDel NDA for Nitroglycerin Lingual Spray is Accepted for Review by FDA
Jun 21, 2004NovaDel Pharma files for US FDA approval of Nitroglycerin Lingual Spray, its first product

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide